Social Capital Hedosophia Holdings Corporation III (NYSE:IPOC) shareholders approved its business combination with Medicaid insurer Clover Health at a special meeting earlier today.
The company said in a press release that 65% of shares participated in the vote and about 99.5% voted in favor of the deal. Social Capital III initially announced its $3.7 billion deal with Clover Health on October 6. Clover is the fastest-growing private insurer covering members through the Medicaid Advantage program.
The parties aim to close the transaction tomorrow, January 7, which will be the last day Social Capital III will trade on the NYSE. The combined entity’s shares and warrants are then to transfer to the Nasdaq and trade under the ticker symbols “CLOV” and “CLOVW,” respectively beginning January 8.
Clover CEO Vivek Garipalli told CNBC at the time of the deal announcement that the company was initially set on an IPO track in early 2020. But, uncertainty about potential healthcare policy changes under a new administration made a SPAC-listing an easier path. That political change is now a reality, but has not dampened market enthusiasm for Clover as it opened at $15.39 ahead of the vote.
This was a significantly more confident trading value that Social Capital I (NYSE:SPCE) had going into the morning of its approval vote for Virgin Galactic in 2019, which opened at $10.62 at the time. But, the Clover transaction for now remains the market’s second favorite Chamath Palihapitiya SPAC production, with Social Capital II’s (NYSE:OPEN) deal with OpenDoor opening at $26.69 ahead of its December 17 approval vote and now trades above $27.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...